Abstract
Neisseria meningititidis infection may present as meningitis or as severe, fulminant sepsis. In order to classify individual patients early according to the expected course of the disease, we developed a score named Neisseria sepsis index [NESI]. The NESI was defined using the parameters heart rate, mean arterial blood pressure, base excess and presence of acute subcutaneous bleeding and/or skin necroses (minimal value [=no evidence for sepsis] NESI 0; maximum value [=most severe sepsis] NESI 8). Seventeen patients with documented, systemicN. meningitidis infection were prospectively assessed for the terminal complement complex (TCC), serum tumour necrosis factorα (TNFα) levels (as laboratory parameters for severity of sepsis) and NESI score. The evaluation was immediately performed when the patients were admitted to the hospital. The 17 patients showed the following distribution of data: NESI 0 (n=4), NESI 1 (n=6), NESI 2 (n=0), NESI 3 (n=1), NESI 4 (n=2), NESI 5 (n=1), NESI 6 (n=0), NES( 7 (n=1), NESI 8 (n=1). Mortality was 4/17 patients, all had NESI ≧5. TCC values ranged from 647–6461 ng/ml (normal range: 130–360 ng/ml); and was not correlated to NESI. TNFα values ranged from 10–910 pg/ml and were correlated to NESI (r 2=0.71,n=17,P<0.001). In patients with fatal outcome, TNFα was 600±160 pg/ml (mean±SEM) and in surviving patients 130±50 pg/ml (mean ± SEM). TNFα was increased in 15/17 patients when compared to normal controls (<27 pg/ml).
Conclusion
The NESI is based on few clinical, objective data, that are available in every hospital. NESI appears to offer an instrument: (1) for making decisions in regard to appropriate monitoring and treatment of vital organ function; and (2) for assessing the quality of care for this life-threatening infection.
Similar content being viewed by others
Abbreviations
- BE :
-
base excess
- GMSPS :
-
Glasgow meningococcal septicaemia prognostic score
- HR :
-
heart rate
- MAP :
-
mean arterial blood pressure
- NESI :
-
Neisseria sepsis index
- TCC :
-
terminal complement complex
- TNFα :
-
tumour necrosis factor-alpha
References
Abdalla EA (1987) Prognosis of meningococcal septicaemia. Lancet II: 861
Algren JT, Lal S, Cutliff SA, Richman BJ (1993) Predictors of outcome in acute meningococcal infection in children. Crit Care Med 21: 447–452
Bone RC (1991) The pathogenesis of sepsis. Ann Intern Med 115(6): 457–469
Boslego JW, Tramont EC (1992) Neisseria meningitidis. In: Gorbach SL, Bartlett JG, Blacklow NR (eds) Infectious diseases. W. B. Saunders, Philadelphia, pp 1452–1458
Brandtzaeg P, Mollnes TE, Kierulf P (1989) Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis 160: 58–65
Frasch CE, Zollinger WD, Poolamn JT (1985) A proposed nomenclature for designation of serotypes within Neisseria meningitidis. Carbohydr Res 112: 105–109
Genoff MC, Hoffer MM, Achauer B, Formosa P (1992) Extremity amputations in meningococcemia-induced purpura fulminans. Plast Reconstr Surg 89: 878–881
Hensel M, Gutjahr P, Kamin W, Schmitt HJ (1992) Meningitis bei 154 Kindern einer Kinderklinik in Deutschland: Klinische und epidemiologische Aspekte. Klin Pädiatr 204/3: 163–170
Knapp JS (1988) Historical perspectives and identification of Neisseria and related species. Clin Microbiol Rev 1: 415–423
Leclerc F, Buescart R, Gullois B, et al (1985) Prognostic factor of severe infectious purpura in children. Intensive Care Med 11: 140–143
Meldepflichtige Krankheiten (1989) In: Statistisches Bundesamt Wiesbaden (ed) Fachserie 12, Gesundheitswesen. Metzler-Poeschel, Stuttgart, pp 7-9
Mollnes TE, Lea T, Frøland SS, Harboe M (1985) Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 22: 197–202
Nürnberger W, Pietsch H, Willers R, Kobler P, Hänsch GM, Seger R, Rodriguez-Valverde V, Schroten H, Hershko C, Tedesco F, Wahn V (1989) Deficiency of the eighth component of complement. Evidence for linkage of C8α-γ pattern with C8β deficiency in sera of twelve patients. Scand J Immunol 30: 45–49
Parillo JE (1993) Mechanisms of disease: pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471–1477
Sinclair JF, Skeoch CH, Hallworth D (1987) Prognosis of meningococcal septicaemia. Lancet II: 38
Thomson APJ, Sills JA, Hart A (1991) Validation of the Glasgow meningococcal septicemia prognostic score: a 10-year retrospective study. Crit Care Med 19/1: 26–30
Verhoel GEG, Schouwer PD, Ceuppens JL, Damme J van, Goossens W, Boogaerts MA (1992) Measurement of serum cytokine levels in patients with myelodysplastic syndromes. Leukemia 6: 1268–1272
Waage A, Hastensen A, Espevik T (1987) Association between tumor necrosis factor in serum and fatal outcome in patients with meningococcal disease. Lancet I: 355–357
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nürnberger, W., Platonov, A., Stannigel, H. et al. Definition of a new score for severity of generalizedNeisseria meningitidis infection. Eur J Pediatr 154, 896–900 (1995). https://doi.org/10.1007/BF01957501
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01957501